Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients

Drug Design, Development and Therapy

Volumn 8, Issue , 2014, Pages 1441-1449

  Dang, Yalong ^a   Mu, Yalin ^b   Li, Lin ^b   Mu, Yahui ^b   Liu, Shujing ^b   Zhang, Chun ^c   Zhu, Yu ^a   Xu, Yimin ^c  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Corticosteroid; Dexamethasone implant; Diabetic retinopathy; Inflammation; Intravitreal triamcinolone acetonide; Pseudophakic cystoid macular edema

Indexed keywords

DEXAMETHASONE; TRIAMCINOLONE ACETONIDE; DRUG IMPLANT;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CASE STUDY; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONJUNCTIVAL HEMORRHAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE SAFETY; DIABETES MELLITUS; DRUG EFFICACY; DRUG IMPLANT; DRUG SAFETY; DRUG TOLERABILITY; ENDOPHTHALMITIS; EYE PAIN; FEMALE; FOLLOW UP; HUMAN; IMPLANT MIGRATION; INFLAMMATION; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MEDICAL DEVICE COMPLICATION; NONINFECTIOUS INFLAMMATION; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETREATMENT; SECONDARY INFECTION; VISUAL ACUITY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DIABETES COMPLICATIONS; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; PSEUDOPHAKIA; TREATMENT OUTCOME;

AGED; DEXAMETHASONE; DIABETES COMPLICATIONS; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; PSEUDOPHAKIA; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 84908060596     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S66611     Document Type: Article

References (24)

1. Yonekawa Y, Kim IK. Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2012;23(1):26-32.
2. Lobo C. Pseudophakic cystoid macular edema. Ophthalmologica. 2012;227(2):61-67.
3. Hayashi K, Igarashi C, Hirata A, Hayashi H. Changes in diabetic macular oedema after phacoemulsification surgery. Eye (Lond). 2009;23(2):389-396.
4. Horozoglu F, Yanyali A, Aytug B, Nohutcu AF, Keskinbora KH. Macular thickness changes after phacoemulsification in previously vitrectomized eyes for diabetic macular edema. Retina. 2011;31(6):1095-1100.
5. Ahmadabadi HF, Mohammadi M, Beheshtnejad H, Mirshahi A. Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification. J Cataract Refract Surg. 2010;36(6):917-922.
6. Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003;135(2):246-249.
7. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol. 2003;136(2):384-386.
8. Jonas JB. Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res. 2006;38(4):218-245.
9. Zalewski D, Raczyńska D, Raczyńska K. Five-month observation of persistent diabetic macular edema after intravitreal injection of Ozurdex implant. Mediators Inflamm. 2014;2014: Article ID 364143.
10. Parravano M, Oddone F, Boccassini B, et al. Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in macular edema due to retinal vein occlusion. Ophthalmic Res. 2014;51(3):153-160.
11. Pichi F, Specchia C, Vitale L, et al. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion. Am J Ophthalmol. 2014;157(3):607-615. e1.
12. Northern California Retina Vitreous Associates. Ozurdex for combined pseudophakic cystoid macular edema and diabetic macular edema after cataract surgery. Available from: http://clinicaltrials.gov/ct2/show/NCT01284478. NLM identifier: NCT01284478. Accessed January 6, 2014.
13. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003;135(2):194-205.
14. Adhi M, Aziz S, Muhammad K, Adhi MI. Macular thickness by age and gender in healthy eyes using spectral domain optical coherence tomography. PLoS One. 2012;7(5):e37638.
15. Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol. 1992;76(4):221-224.
16. Kuppermann BD, Blumenkranz MS, Haller JA, et al; Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125(3):309-317.
17. Williams GA, Haller JA, Kuppermann BD, et al; Dexamethasone DDS Phase II Study Group. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol. 2009;147(6):1048-1054. e1-2.
18. Callanan DG, Gupta S, Boyer DS, et al; Ozurdex PLACID Study Group. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology. 2013;120(9):1843-1851.
19. Haller JA, Kuppermann BD, Blumenkranz MS, et al; Dexamethasone DDS Phase II Study Group. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol. 2010;128(3):289-296.
20. Haller JA, Bandello F, Belfort R Jr, et al; Ozurdex GENEVA Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011;118(12):2453-2460.
21. Blumenkranz MS, Haller JA, Kuppermann BD, et al. Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina. 2010; 30(7):1090-1094.
22. Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR, Aiello LP, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114(3):525-536.
23. Rhee DJ, Peck RE, Belmont J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006;90(8):999-1003.
24. Kocabora MS, Yilmazli C, Taskapili M, Gulkilik G, Durmaz S. Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone. Clin Ophthalmol. 2008;2(1): 167-171.